Scinai Immunotherapeutics SCNI Balance Sheet (2015-2026)

NASDAQ SCNI
$0.75 0.00 (-0.32%)
At close: Oct 19, 2026 · 4:00 PM EDT
Reported Financials

Scinai Immunotherapeutics Quarterly Balance Sheet

Periods 37 quarters
Latest Jun 2026

Scinai Immunotherapeutics reported total assets of $17.18M and total liabilities of $5.44M for the quarter ended Jun 2026, up 27.7% year over year. This balance sheet covers 37 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Mar2015 Jun2015 Dec2015 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Jun2019 Sep2019 Dec2019 Jun2020 Sep2020 Dec2020 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Jun2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
2.93M12.26M10.74M17.41M15.39M11.29M8.31M14.08M10.80M7.51M6.36M4.87M4.83M3.08M1.03M1.96M0.99M1.66M2.96M2.65M
Short-term InvestmentsInvestments (Current)
Cash & Current Investments
2.93M12.26M10.78M17.41M15.39M11.42M8.31M14.08M10.80M7.51M6.36M4.87M4.83M3.08M1.03M1.96M0.99M1.66M2.96M2.65M
Receivables - NetNet Receivables
0.37M0.81M0.44M0.33M0.20M0.18M0.20M0.12M0.12M0.08M0.14M0.07M0.15M0.07M
Receivables - OtherOther Receivables
0.16M5.83M0.15M-7.25M
Receivables
0.37M0.81M0.44M0.33M0.20M0.18M0.20M0.12M0.12M0.08M0.14M-7.17M0.15M0.07M
Prepaid Assets
0.30M0.23M0.16M0.12M0.14M0.23M0.44M0.29M0.32M0.33M0.21M0.24M0.17M0.35M0.56M
Current Assets
3.31M13.07M11.18M17.73M11.46M8.51M14.37M11.05M7.77M6.71M5.45M5.25M3.66M1.62M2.39M1.51M2.05M3.61M3.49M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
12.33M11.98M11.96M12.41M12.51M11.21M11.06M11.25M10.82M10.80M10.66M10.83M10.67M10.18M9.69M9.19M8.50M7.79M10.99M10.71M
Long-Term Investments
Other Non-Current Assets
0.15M0.14M0.14M0.14M0.14M0.14M0.14M0.13M0.13M0.12M0.14M0.14M0.14M0.14M0.13M0.14M0.15M0.15M0.20M
Non-Current Assets
14.40M14.00M13.97M14.35M12.99M12.58M12.70M12.25M12.13M11.87M12.03M11.80M11.19M10.64M11.06M10.33M9.57M13.97M13.69M
Assets
17.71M27.07M25.09M32.09M24.45M21.09M27.07M23.29M19.90M18.58M17.47M17.05M14.85M12.26M13.45M11.84M11.63M17.59M17.18M
Liabilities
Current Liabilities
Accounts Payables
0.58M0.81M1.03M1.00M1.29M0.59M0.30M0.72M1.31M0.65M0.55M0.54M0.93M0.66M0.43M0.38M0.66M0.41M0.78M0.84M
Notes Payables
0.24M0.38M0.25M0.25M0.32M0.38M0.39M0.38M0.40M0.39M0.36M0.36M0.42M0.50M0.33M0.35M0.37M
Payables
0.58M0.81M1.03M1.00M1.55M0.59M0.62M1.10M1.31M1.05M0.93M0.93M1.32M1.02M0.79M0.80M1.16M0.74M1.13M1.21M
Accumulated Expenses
0.36M0.76M0.46M0.53M0.44M
Other Accumulated Expenses
0.52M1.07M1.13M0.54M0.62M1.24M0.85M0.84M0.61M0.85M0.61M0.65M0.60M1.01M0.96M0.85M1.55M1.02M
Current Leases
0.20M0.25M
Current Deferred Revenue
0.23M0.09M
Total Current Liabilities
19.98M21.33M21.76M2.32M6.72M1.48M2.34M2.58M1.89M1.54M1.78M1.93M1.67M1.39M1.81M2.12M1.59M2.69M2.23M
Non-Current Liabilities
Non-Current Debt
19.97M27.16M5.35M0.24M20.08M21.85M23.29M18.60M19.37M19.51M19.82M0.28M0.26M0.29M0.29M0.29M0.29M
Pension
0.03M0.03M0.03M0.03M0.03M
Operating Leases
1.89M1.83M1.45M1.76M1.58M1.31M1.08M1.01M0.93M0.82M0.80M0.73M0.64M0.58M1.40M1.57M1.64M2.86M2.93M
Other Non-Current Liabilities
0.18M5.33M2.66M0.90M0.31M0.10M0.00M0.00M0.00M0.00M-12.49M
Total Non-Current Liabilities
2.28M2.24M2.03M22.25M16.45M16.97M26.49M25.52M25.12M19.74M20.26M20.24M20.46M0.87M1.67M1.86M1.94M3.14M3.21M
Total Liabilities
22.25M23.57M23.88M24.57M23.45M18.45M28.83M28.10M27.01M21.27M22.04M22.17M22.14M2.26M3.47M3.98M3.52M5.83M5.44M
Shareholder's Equity
Total Debt
20.21M27.54M0.25M5.59M0.56M20.46M21.85M23.69M18.98M19.76M19.90M20.18M0.64M0.68M0.79M0.62M0.64M0.65M
Common Equity
-4.54M3.50M1.30M7.52M-0.86M3.26M2.64M-1.76M-4.81M-7.11M-2.69M-4.57M-5.12M-7.28M10.00M9.98M7.86M8.10M11.76M11.73M
Liabilities and Shareholders Equity
17.71M27.07M25.19M32.09M24.74M21.09M27.07M23.29M19.90M18.58M17.47M17.05M14.85M12.26M13.45M11.84M11.63M17.59M17.18M
Retained Earnings
-101.08M-106.06M-109.64M-117.51M-117.82M-110.58M-108.18M-115.84M-119.35M-123.11M-120.01M-122.34M-124.49M-126.82M-115.31M-117.54M-121.67M-125.85M-122.27M-124.27M
Preferred Shares
5.63M5.63M5.63M5.63M

Scinai Immunotherapeutics Balance Sheet API

Pull Scinai Immunotherapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SCNI&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY